Archangels Bbi (Kcp Nominees) Limited investment portfolio

1NHALER Ltd develops a propellant‑free, cardboard‑based single‑dose dry‑powder inhaler that folds from a flat credit‑card shape into a three‑dimensional device, using patented membrane dispersion technology to deliver a range of inhalable medicines. The company partners with pharmaceutical organisations and public‑health bodies to provide low‑cost, portable inhalation therapy for conditions such as asthma, epilepsy, allergies and Parkinson’s disease.

Biocaptiva Ltd develops liquid‑biopsy technology, including the BioCaptor cell‑free DNA capture device that uses its proprietary msX™ polymer to extract and preserve nucleic acids from blood samples. Its products are aimed at cancer diagnostics and precision‑medicine applications.